Peritoneal endometriosis and “endometriotic” nodules of the rectovaginal septum are two different entities
Open accessAbstract
Objective To compare histologically and stereologically the endometriotic nodule of the rectovaginal septum to peritoneal endometriosis.Design Morphometric investigation, cytokeratin and vimentin content, and steroid receptor evaluation were performed on endometriotic tissue from the peritoneum (n = 52) and rectovaginal nodules (n = 68).Setting An academic teaching hospital.Patients Biopsies were taken from 120 patients undergoing a laparoscopy for infertility and/ or pelvic pain (52 from typical black peritoneal endometriotic implants and 68 from endometriotic nodule of the rectovaginal septum). None of the patients were treated.Results Mitotic activity was found to be significantly different in peritoneal and rectovaginal endometriosis. The evaluation suggested that the stroma is not mandatory for the invasion of glandular epithelium in the rectovaginal nodule, which is, like a adenomyoma, a circumscribed nodular aggregate of smooth muscle and glandular elements. Cytokeratin and vimentin content as well as the estrogen receptor (ER) and P receptor (PR) content were significantly lower in both types of lesion when compared with eutopic endometrium. But vimentin immunoreactivity in epithelium, as well as the ER and PR content, were significantly lower in nodules when compared with black peritoneal lesions.Conclusion It is suggested that the rectovaginal endometriotic nodule is a different disease from peritoneal endometriosis and must be called rectovaginal adenomyosis or rectovaginal adenomyoma. Its histopathogenesis probably is not related to the implantation of regurgitated endometrial cells but to the metaplasia of Müllerian rests.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Red endometriotic lesions are very active, with high proliferative activity and VEGF and MMP content, explaining their frequent bleeding and remodeling during the menstrual period.
“Red lesions were found to be very active, with high proliferative activity and vascular endothelial growth factor (VEGF) and matrix metalloproteinase (MMP) content, explaining their frequent bleeding and remodeling during the menstrual period [46,47,48].”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [47]
Red lesions are resistant to progestin therapy, which may induce some decidualization, but not atrophy.
“These red lesions are resistant to progestin therapy, which may induce some decidualization, but not atrophy [46,47,48].”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [47]
Progesterone resistance is an explanation for why 33% of patients do not respond to OCPs and progestins, with this percentage climbing even higher in women with deep nodular endometriosis.
“In the present paper, we thoroughly scrutinized the concept of progesterone resistance as an explanation for why 33% of patients do not respond to OCPs and progestins, with this percentage climbing even higher in women with deep nodular endometriosis [46,47,56,58].”
From Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review (2021) · cites this paper as [47]
The citation lists haven’t been fetched yet
References 29 · Cited by 147
- Authors
- Donnez, J., Nisolle, M., Smoes, P., Gillet, N., Beguin, S., & Casanas-Roux, F.
- Affiliations
- Cliniques Universitaires Saint-Luc (BE)
- ORCID
- Nisolle, Michelle
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 1996-09
- Volume
- 66
- Issue
- 3
- Pages
- 362-368
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W1754070801
- Cited by
- 147
- References
- 29
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 5 · 2019: 3 · 2017: 1 · 2016: 3 · 2015: 5 · 2014: 6 · 2013: 7 · 2012: 6
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Fertility and Sterility (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (submittedVersion)
- Open Repository and Bibliography (University of Liège) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ectopic Pregnancy Diagnosis and Management
- Keywords
- peritoneal endometriosis, mitotic activity, estrogen receptor, progesterone receptor, vimentin, cytokeratin, eutopic endometrium, pelvic pain, infertility
- MeSH terms
- Biopsy, Diagnosis, Differential, Endometriosis, Endometrium, Epithelium, Female, Humans, Immunohistochemistry, Keratins, Mitosis, Peritoneal Diseases, Receptors, Estrogen, Receptors, Progesterone, Rectal Diseases, Vaginal Diseases, Vimentin, Endometrial Neoplasms, Adenomyoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review